Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: Swedish Thunberg said on Instagram she had now recovered from symptoms milder than her latest cold, and may not have suspected COVID-19 had it not been for her father, who had travelled with her, developing more severe symptoms. “Many (especially young people) might not notice any symptoms at all, or very mild symptoms. Then they don’t know they have the virus and can pass it on to people in risk groups,” she said. “We who don’t belong to a risk group have an enormous responsibility, our actions can be the difference between life and death for many others. Please keep that in mind, follow the advice from experts and your local authorities and #StayAtHome to slow the spread of the virus.”  The founder of the Fridays for Future youth movement said she had not been tested for the virus but given the combined symptoms and circumstances it was very likely she had it. She had self isolated because she had visited countries hit by coronavirus infection. Fridays for Future calls on politicians to listen to climate scientists and take urgent action to against global warming. Claim: Greta Thunberg says probably had COVID-19, urges #StayAtHome.

Output: Teen climate activist Greta Thunberg said on Tuesday that while self-isolating after recent travels in Europe she probably came down with COVID-19, and urged other young people to stay at home too if even just a little unwell, to help stop the coronavirus.


Input: Consider Input: Paragraph: At issue are genes called BRCA1 and BRCA2. When they’re mutated, the body can’t repair damaged DNA as well, greatly increasing the chances of breast, ovarian and certain other cancers. Gene testing allows affected women to consider steps to lower their risk, such as when actress Angelina Jolie underwent a preventive mastectomy several years ago. Most cancer isn’t caused by BRCA mutations — they account for 5% to 10% of breast cancers and 15% of ovarian cancers — so the gene tests aren’t for everyone. But mutations cluster in families, and the U.S. Preventive Services Task Force has long recommended that doctors screen women who have relatives with BRCA-related cancers and refer those who might benefit from gene testing to a genetic counselor to help them decide. Tuesday, the task force expanded that advice, telling primary care doctors they should also assess women’s risk if: —they previously were treated for breast or other BRCA-related cancers including ovarian, fallopian tube or peritoneal cancers, and now are considered cancer-free. —their ancestry is prone to BRCA mutations, such as Ashkenazi Jewish women. Why screen breast cancer survivors? After all, they already know there’s a risk of recurrence. Take, for example, someone who had a tumor removed in one breast in their 40s a decade ago, when genetic testing wasn’t as common. Even this many years later, a BRCA test still could reveal if they’re at risk for ovarian cancer — or at higher than usual risk for another tumor in their remaining breast tissue, explained task force member Dr. Carol Mangione of the University of California, Los Angeles. And it could alert their daughters or other relatives to a potential shared risk. “It’s important to test those people now,” Mangione said. “We need to get the word out to primary care doctors to do this assessment and to make the referrals.” Private insurers follow task force recommendations on what preventive care to cover, some at no out-of-pocket cost under rules from former President Barack Obama’s health care law. The recommendations were published in the Journal of the American Medical Association. Cancer groups have similar recommendations for BRCA testing, and increasingly urge that the newly diagnosed be tested, too, because the inherited risk can impact choices about surgery and other treatment. Identifying BRCA mutation carriers “can be lifesaving, and should be a part of routine medical care,” Drs. Susan Domchek of the University of Pennsylvania and Mark Robson of Memorial Sloan Kettering Cancer Center, who weren’t involved with the new guidelines, wrote in an editorial accompanying them. But too few high-risk women ever learn if they harbor BRCA mutations, they wrote. For example, cancer groups have long recommended that all ovarian cancer patients be tested, but several studies have found testing is done in less than a third. Don’t skip the genetic counseling, said the task force’s Mangione. BRCA testing can cause anxiety and sometimes gives confusing results, finding mutations that might not be dangerous — things the counselors are trained to interpret. There’s a shortage of genetic counselors, particularly in rural areas, and she said counseling by phone can work. There’s a wide array of gene tests, some that search just for BRCA mutations and others that test dozens of additional genes at the same time. There’s even a direct-to-consumer kit sold by 23andMe — but Domchek and Robson warned it only detects the three mutations found most in women of Ashkenazi Jewish descent, not dozens of other mutations. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Claim: Guidelines say more women may need breast cancer gene test.

Output: More women may benefit from gene testing for hereditary breast or ovarian cancer, especially if they’ve already survived cancer once, an influential health group recommended Tuesday.


Input: Consider Input: Paragraph: The World Organization for Animal Health said routine surveillance testing confirmed on Monday the presence of a low-pathogenic N5N2 virus in a flock of 40,000 turkeys in Kandiyohi County, Minnesota’s top turkey producing county. The virus originated in wild birds. The state Board of Animal Health said only one of four barns on the farm, housing 10,000, 13-week-old toms, was affected. The flock has been quarantined but has shown no signs of illness, the agencies said. The farm will be allowed to market the birds normally in a few weeks once the flock tests negative, said Dr. Shauna Voss, senior veterinarian at the board’s poultry testing laboratory in Willmar. The board has stepped up surveillance at nearby poultry farms as a precaution. The virus is different from the highly pathogenic H5N2 virus that caused a massive outbreak in U.S. turkeys and chickens in 2015, which resulted in the deaths of more than 50 million birds. Iowa and Minnesota were by far the hardest hit states. Losses across the U.S. economy were estimated at $3.3 billion. Voss said this was the first detection of any avian influenza virus in commercial poultry in Minnesota since that outbreak, although there was a low-pathogenic case in western Wisconsin last year. The 2015 outbreak led to tighter biosecurity measures on poultry farms to protect them from outside sources of infection, such as wild birds, rodents and farm workers who might track in viruses on their footwear or clothing. Producers now conduct enhanced surveillance during the spring and fall migrations, Voss said. The new detection shows that those security measures have paid off, she said. Claim: Mild form of bird flu found in Minnesota turkey flock.


Output: A mild form of bird flu detected in one flock of turkeys in a west-central Minnesota county is not the same virus that caused a devastating outbreak in 2015 and poses no public health or food safety risk, officials said Tuesday.